1. Oncogene. 2021 Aug;40(31):5042-5048. doi: 10.1038/s41388-021-01879-2. Epub
2021  Jun 17.

Combination of chemotherapy with BRAF inhibitors results in effective 
eradication of malignant melanoma by preventing ATM-dependent DNA repair.

Alonso-Marañón J(1)(2), Villanueva A(3), Piulats JM(4), Martínez-Iniesta M(5), 
Solé L(1)(2), Martín-Liberal J(4), Segura S(6), Pujol RM(2)(6), Iglesias M(7), 
Bigas A(8)(9)(10), Gallardo F(11)(12), Espinosa L(13)(14).

Author information:
(1)Stem Cells and Cancer Research Laboratory-IMIM, CIBERONC, Barcelona, Spain.
(2)Cancer Research Program Hospital del Mar Medical Research Institute (IMIM), 
Barcelona, Spain.
(3)Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer 
Therapeutic Resistance (ProCURE), ICO, Oncobell Program, IDIBELL, L'Hospitalet 
del Llobregat, Barcelona, Spain. avillanueva@iconcologia.net.
(4)Medical Oncology Department, Catalan Institute of Cancer (ICO), 
IDIBELL-OncoBell, Hospitalet de Llobregat, CIBERONC, Barcelona, Spain.
(5)Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer 
Therapeutic Resistance (ProCURE), ICO, Oncobell Program, IDIBELL, L'Hospitalet 
del Llobregat, Barcelona, Spain.
(6)Department of Dermatology, Institut Hospital del Mar d'Investigacions 
Mèdiques (IMIM) and Universitat Autònoma, Barcelona, Spain.
(7)Department of Pathology, Institut Mar d'Investigacions Mèdiques, Universitat 
Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
(8)Stem Cells and Cancer Research Laboratory-IMIM, CIBERONC, Barcelona, Spain. 
abigas@imim.es.
(9)Cancer Research Program Hospital del Mar Medical Research Institute (IMIM), 
Barcelona, Spain. abigas@imim.es.
(10)Institut Josep Carreras contra la Leucemia (IJC), Barcelona, Spain. 
abigas@imim.es.
(11)Cancer Research Program Hospital del Mar Medical Research Institute (IMIM), 
Barcelona, Spain. fgallardo@parcdesalutmar.cat.
(12)Department of Dermatology, Institut Hospital del Mar d'Investigacions 
Mèdiques (IMIM) and Universitat Autònoma, Barcelona, Spain. 
fgallardo@parcdesalutmar.cat.
(13)Stem Cells and Cancer Research Laboratory-IMIM, CIBERONC, Barcelona, Spain. 
lespinosa@imim.es.
(14)Cancer Research Program Hospital del Mar Medical Research Institute (IMIM), 
Barcelona, Spain. lespinosa@imim.es.

Invasive malignant melanoma (MM) is an aggressive tumor with no curative therapy 
in advanced stages. Chemotherapy has not demonstrated its efficacy in MM and 
current treatment for tumors carrying the most frequent BRAFV600E mutation 
consists of BRAF inhibitors alone or in combination with MAPK pathway 
inhibitors. We previously found that BRAF inhibition prevents activation of the 
DNA-damage repair (DDR) pathway in colorectal cancer thus potentiating the 
effect of chemotherapy. We now show that different chemotherapy agents inflict 
DNA damage in MM cells, which is efficiently repaired, associated with 
activation of the ATM-dependent DDR machinery. Pharmacologic inhibition of BRAF 
impairs ATM and DDR activation in these cells, leading to sustained DNA damage. 
Combination treatments involving DNA-damaging agents and BRAF inhibitors 
increase tumor cell death in vitro and in vivo, and impede MM regrowth after 
treatment cessation. We propose to reconsider the use of chemotherapy in 
combination with BRAF inhibitors for MM treatment.

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

DOI: 10.1038/s41388-021-01879-2
PMID: 34140639 [Indexed for MEDLINE]